Biomarkers Of Brain Injury - EP2628013

The patent EP2628013 was granted to The Johns Hopkins University on Jun 12, 2019. The application was originally filed on Oct 14, 2011 under application number EP11833480A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2628013

THE JOHNS HOPKINS UNIVERSITY
Application Number
EP11833480A
Filing Date
Oct 14, 2011
Status
Granted And Under Opposition
May 10, 2019
Grant Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKAMar 11, 2020WITHDRAWN

Patent Citations (59) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2001021534
DESCRIPTIONUS2002086335
DESCRIPTIONUS2002137234
DESCRIPTIONUS2002138208
DESCRIPTIONUS2002193950
DESCRIPTIONUS2003003460
DESCRIPTIONUS2003004402
DESCRIPTIONUS2003055615
DESCRIPTIONUS2003113713
DESCRIPTIONUS2003124572
DESCRIPTIONUS2004022677
DESCRIPTIONUS2005052646
DESCRIPTIONUS2005142033
DESCRIPTIONUS2006019319
DESCRIPTIONUS2006172340
DESCRIPTIONUS2009006339
DESCRIPTIONUS2009065357
DESCRIPTIONUS2009170121
DESCRIPTIONUS5242828
DESCRIPTIONUS5270163
DESCRIPTIONUS5475096
DESCRIPTIONUS5567588
DESCRIPTIONUS5595877
DESCRIPTIONUS5637459
DESCRIPTIONUS5660985
DESCRIPTIONUS5670637
DESCRIPTIONUS5683867
DESCRIPTIONUS5696249
DESCRIPTIONUS5707796
DESCRIPTIONUS5719060
DESCRIPTIONUS5866434
DESCRIPTIONUS6011020
DESCRIPTIONUS6090545
DESCRIPTIONUS6140045
DESCRIPTIONUS6207369
DESCRIPTIONUS6225047
DESCRIPTIONUS6319670
DESCRIPTIONUS6329209
DESCRIPTIONUS6362011
DESCRIPTIONUS6413783
DESCRIPTIONUS6537749
DESCRIPTIONUS6673533
DESCRIPTIONUS6919173
DESCRIPTIONUS6977722
DESCRIPTIONUS7036946
DESCRIPTIONUS7052861
DESCRIPTIONUS7288410
DESCRIPTIONUS7491540
DESCRIPTIONUS7497997
DESCRIPTIONWO0056934
DESCRIPTIONWO0131580
DESCRIPTIONWO03048768
INTERNATIONAL-SEARCH-REPORTUS2008131881
INTERNATIONAL-SEARCH-REPORTUS2008220013
INTERNATIONAL-SEARCH-REPORTUS2009068691
INTERNATIONAL-SEARCH-REPORTUS7396654
INTERNATIONAL-SEARCH-REPORTUS7427490
SEARCHUS2008131881
SEARCHWO2012155134

Non-Patent Literature (NPL) Citations (13) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- DE VOS et al., "Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke", BMC Neurology, (20170000), vol. 17, page 170-
OPPOSITION- KVARTSBERG et al., "Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls", Alzheimer's Research & Therapy, (20150000), vol. 7, page 40-
OPPOSITION- MONS et al., "Selective age-related changes in the PKC-sensitive, calmodulin-binding protein, neurogranin, in the mouse brain", Journal of Neurochemistry, (20010000), vol. 79, pages 859 - 867-
OPPOSITION- DE VOS et al., "C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease", Alzheimer's & Dementia, (20150000), vol. 11, doi:10.1016/j.jalz.2015.05.012, pages 1461 - 1469, XP029351159
OPPOSITION- PELINKA et al., "Glial Fibrillary Acidic Protein in Serum After Traumatic Brain Injury and Multiple Trauma", Journal of Trauma, (20040000), vol. 57, doi:10.1097/01.TA.0000108998.48026.C3, pages 1006 - 1012, XP009511820
OPPOSITION- LANGE et al., "Evaluation of Eight Plasma Proteins as Candidate Blood- Based Biomarkers for Malignant Gliomas", Cancer Invest., (20140000), vol. 32, no. 8, doi:10.3109/07357907.2014.933237, pages 423 - 429, XP008181989
SEARCH[ ] - BLOOD, 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009, (200911), vol. 114, no. 22, ISSN 0006-4971(print), pages 1012 - 1013-
SEARCH[ ] - BLOOD, 51ST ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; NEW ORLEANS, LA, USA; DECEMBER 05 -08, 2009, (200911), vol. 114, no. 22, ISSN 0006-4971(print), pages 606 - 607-
SEARCH- LATERZA O F ET AL, "Biomarkers of tissue injury", BIOMARKERS IN MEDICINE, FUTURE MEDICINE, LONDON, (20080201), vol. 2, no. 1, ISSN 1752-0363, pages 71 - 82, XP009150572 [I] 11-14 * page 88, column l, paragraph l - page 89, paragraph 2; table 4 * * abstract * * page 86, paragraph 2 - column r, paragraph 1 *-
SEARCH- SAVAGE WILLIAM J ET AL, "Glial Fibrillary Acidic Protein as a Plasma Biomarker of Brain Injury in Children with Sickle Cell Disease.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200911), Database accession no. PREV201000352506, XP002719027 [A] 1,2,11-14 * Introduction and Conclusions *-
SEARCH- WILLIAMS LISA M ET AL, "Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200911), Database accession no. PREV201000353573, XP002719028 [A] 1,2,11-14 * abstract *-
SEARCH- SAVAGE WILLIAM J ET AL, "Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.", ACTA HAEMATOLOGICA 2011, (2011), vol. 125, no. 3, ISSN 1421-9662, pages 103 - 106, XP002719029 [A] 1,2,11-14 * Published online 24-11-2010; see abstract. *
SEARCH- HOSHI T ET AL, "Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction", STROKE, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 36, no. 4, doi:10.1161/01.STR.0000158915.28329.51, ISSN 0039-2499, (20050401), pages 768 - 772, (20050303), XP002578974 [A] 1,2,11-14 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents